Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.140
-0.100 (-8.06%)
At close: Mar 28, 2025, 4:00 PM
1.130
-0.010 (-0.88%)
After-hours: Mar 28, 2025, 7:59 PM EDT
PACB Revenue
In the year 2024, Pacific Biosciences of California had annual revenue of $154.01M, down -23.19%. Pacific Biosciences of California had revenue of $39.22M in the quarter ending December 31, 2024, a decrease of -32.79%.
Revenue (ttm)
$154.01M
Revenue Growth
-23.19%
P/S Ratio
2.03
Revenue / Employee
$267,850
Employees
575
Market Cap
339.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 154.01M | -46.51M | -23.19% |
| Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
| Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
| Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
| Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
PACB News
- 1 day ago - Pacific Biosciences Names Jim Gibson Chief Financial Officer - Market Watch
- 1 day ago - Jim Gibson to join PacBio as Chief Financial Officer - GlobeNewsWire
- 11 days ago - Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes - GlobeNewsWire
- 4 weeks ago - Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock - Seeking Alpha
- 5 weeks ago - PacBio to Participate in TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 6 weeks ago - PacBio Grants Equity Incentive Award to New Employee - GlobeNewsWire
- 6 weeks ago - Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Trump's Cuts to Medical Research Are Hurting These Stocks - Barrons